clofibrate has been researched along with Vascular Diseases in 12 studies
angiokapsul: contains clofibrate & insoitolnicotinate
Vascular Diseases: Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ankle systolic pressure measurements in 67 patients with intermittent claudication treated with Clofibrate for an average period of 11 months and 32 untreated patients suggest that 1) patients with a raised initial plasma fibrinogen concentration have more severe disease than those with low initial plasma fibrinogen concentration and 2) the response to treatment with Clofibrate is significantly better in those with a raised plasma fibrinogen concentration." | 7.65 | Results of ankle ststolic pressure measurements in patients with intermittent claudication being treated with clofibrate. ( Dormandy, JA; Postlethwaite, JC, 1975) |
| "Ankle systolic pressure measurements in 67 patients with intermittent claudication treated with Clofibrate for an average period of 11 months and 32 untreated patients suggest that 1) patients with a raised initial plasma fibrinogen concentration have more severe disease than those with low initial plasma fibrinogen concentration and 2) the response to treatment with Clofibrate is significantly better in those with a raised plasma fibrinogen concentration." | 3.65 | Results of ankle ststolic pressure measurements in patients with intermittent claudication being treated with clofibrate. ( Dormandy, JA; Postlethwaite, JC, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Verstraete, M | 1 |
| Blakely, JA | 1 |
| Harker, LA | 1 |
| Hirsh, J | 1 |
| Gent, M | 1 |
| Genton, E | 1 |
| Postlethwaite, JC | 1 |
| Dormandy, JA | 1 |
| Rowe, WS | 1 |
| Vogt, HJ | 1 |
| Kwiterovich, PO | 1 |
| Margolis, S | 1 |
| Fourrier, A | 1 |
| Mouton, Y | 1 |
| Scott, PJ | 1 |
| Mitchell, WD | 1 |
| Murchison, LE | 1 |
| Ruhrmann, H | 1 |
| Begg, TB | 1 |
| Rifkind, BM | 1 |
3 reviews available for clofibrate and Vascular Diseases
| Article | Year |
|---|---|
The position of long-term stimulation of the endogenous fibrinolytic system: present achievements and clinical perspectives.
Topics: Adrenocorticotropic Hormone; Anabolic Agents; Androgens; Clofibrate; Coronary Disease; Deamino Argin | 1975 |
Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
Topics: Arteriosclerosis; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clo | 1975 |
Type IV hyperlipoproteinaemia.
Topics: Child; Cholesterol; Chylomicrons; Clofibrate; Diagnosis, Differential; Diet Therapy; Dietary Carbohy | 1973 |
2 trials available for clofibrate and Vascular Diseases
| Article | Year |
|---|---|
Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
Topics: Arteriosclerosis; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clo | 1975 |
[Clinical and biological study of a new vascular protective agent and hypolipemic agent, pyridoxine para-chloro-phénoxy-isobutyrate. (Claresan)].
Topics: Adult; Aged; Clinical Trials as Topic; Clofibrate; Diet, Reducing; Drug Tolerance; Female; Humans; H | 1974 |
8 other studies available for clofibrate and Vascular Diseases
| Article | Year |
|---|---|
Platelet suppressing drugs in arterial disease.
Topics: Anticoagulants; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clofibrate; Humans; Myocardial | 1978 |
Results of ankle ststolic pressure measurements in patients with intermittent claudication being treated with clofibrate.
Topics: Ankle; Blood Flow Velocity; Blood Pressure; Blood Pressure Determination; Blood Viscosity; Clofibrat | 1975 |
Some aspects of the management of the hyperlipidaemias.
Topics: Anion Exchange Resins; Clofibrate; Fats, Unsaturated; Humans; Hypercholesterolemia; Hyperlipidemias; | 1975 |
[Letter: Impotence caused by clofibrate therapy].
Topics: Clofibrate; Erectile Dysfunction; Humans; Male; Vascular Diseases | 1976 |
Editorial: Diet and drugs for hyperlipidaemia.
Topics: Body Height; Body Weight; Clofibrate; Diet; Humans; Hyperlipidemias; Patient Care Planning; Vascular | 1973 |
The effect of clofibrate on serum and faecal lipids.
Topics: Adult; Angina Pectoris; Bile Acids and Salts; Cholesterol; Clofibrate; Feces; Female; Humans; Hyperc | 1972 |
[Serum cholesterol and total serum lipids of psoriasis patients in comparison with healthy persons and other diseases].
Topics: Adolescent; Adult; Aged; Child; Cholesterol; Clofibrate; Eczema; Female; Humans; Hyperlipidemias; Li | 1972 |
[Evaluation of clofibrate therapy in peripheral arteriopathy].
Topics: Adult; Aged; Arteriosclerosis; Cholesterol; Clofibrate; Humans; Intermittent Claudication; Middle Ag | 1971 |